Remove 2013 Remove Concentrates Remove Epilepsy Remove Research and Development
article thumbnail

World Cannabis Market Investments at a Glance

Cannabis Law Report

And all thanks to the latest medical research. If earlier cannabis was a taboo subject due to its psychedelic properties, then with the development of technologies that allow the extraction of pure cannabidiol, the situation has changed radically. The development of new varieties and genetic research.

article thumbnail

What is CBD? Everything you need to know

The Cannigma

Both THC and CBD were first isolated in a laboratory in the early 1940s by American researcher Roger Adams. It wasn’t until the 1960s, however, that Israeli researcher Raphael Mechoulam properly identified the chemical structure of CBD, which led to the wealth of knowledge and scope of research we have today. Shutterstock).

CBD 122
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

By: James Holley, Molecular Biologist, Scientific Officer, Mike Robinson, Co-founder, Research Institute, and Dr. David Ostrow, M.D., Research Director. International Cannabinoid Cancer Research Institute (Draft 5). An Israeli study of cannabis versus epilepsy, however, used natural extracts with a ratio of 20:1 CBD:THC.

article thumbnail

Article: Top 5 APAC Countries for Legal Cannabis

Cannabis Law Report

While much of this development has been concentrated in Europe and the US, several nations in Asia-Pacific have also recently shifted towards greater tolerance. Medical Use & Cannabis Research. in 2013 to 14.5% Medical Use & Cannabis Research. Unfortunately, such costs can quickly become prohibitive.

article thumbnail

The Health Effects of Cannabis: The Nervous System

Healer

. ‘Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology.’ Oral cannabinoids are of unknown efficacy in non-chorea-related symptoms of Huntington disease, Tourette syndrome, cervical dystonia, and epilepsy.

article thumbnail

NO BRAINER: CBD AND THC FOR HEAD INJURIES

Green Relief

The benefits of CBD-rich cannabis concentrates for chronic traumatic encephalopathy (CTE) are well-known among football players and other pro athletes. Preclinical research and anecdotal accounts indicate that CBD is highly active against brain ischemia, modulating many of the molecular hallmarks of TBI pathology. But the U.S.

THC 64
article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

Published by The Journal of Cannabis Research. At the same time, the outlook on cannabis research data is largely positive. Primary sources most frequently used in these reports are peer-reviewed journals or government reports, voices from medical associations or foundations, as well as government and university researchers.